Literature DB >> 15100248

C-kit gene product (CD117) immunoreactivity in canine and feline paraffin sections.

Maria Morini1, Giuliano Bettini, Rosario Preziosi, Luciana Mandrioli.   

Abstract

CD117 is a transmembrane tyrosine kinase growth factor receptor expressed by a variety of normal human cell types, including germ cells, immature myeloid cells, and mast cells. To evaluate the pattern of CD117 expression in dogs and cats, we applied a polyclonal antibody on paraffin sections from 44 samples of normal tissues and 104 tumors. In both species, strong immunoreactivity was observed in mast cells, interstitial cells of Cajal, and in mast cell tumors. Among gastrointestinal mesenchymal neoplasms, tissues from five dogs and one cat revealed strong CD117 expression, enabling us to identify them as gastrointestinal stromal tumors (GISTs).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15100248     DOI: 10.1177/002215540405200515

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  15 in total

1.  Eosinophilia in a cat with acute leukemia.

Authors:  Cornelia Gilroy; María Forzán; Anne Drew; William Vernau
Journal:  Can Vet J       Date:  2011-09       Impact factor: 1.008

2.  Subcutaneous malignant mast cell tumor in a Japanese macaque (Macaca fuscata).

Authors:  Kosuke Tsugo; Tomoe Kinoshita; Ko Kadowaki; Go Sugahara; Emiko Saito; Shigehisa Kawakami; Yumi Une
Journal:  Primates       Date:  2016-10-19       Impact factor: 2.163

3.  The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors.

Authors:  Joshua D Webster; Vilma Yuzbasiyan-Gurkan; John B Kaneene; RoseAnn Miller; James H Resau; Matti Kiupel
Journal:  Neoplasia       Date:  2006-02       Impact factor: 5.715

4.  Investigation of c-KIT and Ki67 expression in normal, preneoplastic and neoplastic canine prostate.

Authors:  Carlos Eduardo Fonseca-Alves; Priscilla Emiko Kobayashi; Chiara Palmieri; Renée Laufer-Amorim
Journal:  BMC Vet Res       Date:  2017-12-06       Impact factor: 2.741

5.  Growth-inhibitory effects of four tyrosine kinase inhibitors on neoplastic feline mast cells exhibiting a Kit exon 8 ITD mutation.

Authors:  Emir Hadzijusufovic; Barbara Peter; Laura Rebuzzi; Christian Baumgartner; Karoline V Gleixner; Alexander Gruze; Tuddow Thaiwong; Winfried F Pickl; Vilma Yuzbasiyan-Gurkan; Michael Willmann; Peter Valent
Journal:  Vet Immunol Immunopathol       Date:  2009-05-18       Impact factor: 2.046

6.  CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markers.

Authors:  Rui M Gil da Costa; Eduarda Matos; Alexandra Rema; Célia Lopes; Maria A Pires; Fátima Gärtner
Journal:  BMC Vet Res       Date:  2007-08-21       Impact factor: 2.741

7.  Intratumoral CD3+ T-lymphocytes immunoexpression and its association with c-Kit, angiogenesis, and overall survival in malignant canine mammary tumors.

Authors:  Maria Isabel Carvalho; Isabel Pires; Marlene Dias; Justina Prada; Hugo Gregório; Luis Lobo; Felisbina Queiroga
Journal:  Anal Cell Pathol (Amst)       Date:  2015-08-05       Impact factor: 2.916

8.  The Relevance of CD117-Immunocytochemistry Staining Patterns to Mutational Exon-11 in c-kit Detected by PCR from Fine-Needle Aspirated Canine Mast Cell Tumor Cells.

Authors:  A Sailasuta; D Ketpun; P Piyaviriyakul; S Theerawatanasirikul; P Theewasutrakul; A Rungsipipat
Journal:  Vet Med Int       Date:  2014-02-18

9.  Increased levels of palmitoylethanolamide and other bioactive lipid mediators and enhanced local mast cell proliferation in canine atopic dermatitis.

Authors:  Francesca Abramo; Luca Campora; Francesco Albanese; Maria Federica della Valle; Luigia Cristino; Stefania Petrosino; Vincenzo Di Marzo; Vincenzo Miragliotta
Journal:  BMC Vet Res       Date:  2014-01-14       Impact factor: 2.741

10.  Stem cell growth factor receptor in canine vs. feline osteosarcomas.

Authors:  Birgitt Wolfesberger; Andrea Fuchs-Baumgartinger; Juraj Hlavaty; Florian R Meyer; Martin Hofer; Ralf Steinborn; Christiane Gebhard; Ingrid Walter
Journal:  Oncol Lett       Date:  2016-08-12       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.